Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acetylsalicylic acid + calcium carbonate is a fixed-dose combination of two active ingredients. Acetylsalicylic acid (commonly known as aspirin) is a non-selective cyclooxygenase (COX) inhibitor that provides analgesic, antipyretic, anti-inflammatory effects and irreversibly inhibits platelet aggregation by blocking COX-1 and COX-2 enzymes. This action reduces the synthesis of prostaglandins and thromboxane A2, leading to pain relief and prevention of blood clots[3][4]. Calcium carbonate acts as an antacid by neutralizing gastric hydrochloric acid and increasing gastric pH; it also serves as a dietary calcium supplement[5][7]. The combination is used for the treatment of mild to moderate pain, fever, inflammatory conditions such as arthritis, prevention of heart attack or stroke due to its antiplatelet effect (from aspirin), while the addition of calcium carbonate helps reduce gastrointestinal irritation caused by aspirin[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetylsalicylic acid + calcium carbonate.